Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-16-024525)

Filing Details

Accession Number:: 0001179110-16-024525
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-13 09:00:40
Reporting Period:: 2016-05-12

Filing Date:: 2016-05-13
Accepted Time:: 2016-05-13 09:00:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
861838	Idera Pharmaceuticals Inc.	IDRA	Biological Products, (No Disgnostic Substances) (2836)	043072298

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1415297	J Mark Casey	C/O Idera Pharmaceuticals, Inc. 167 Sidney Street Cambridge MA 02139	Senior Vp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-05-12	34,450	$1.44	34,450	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The transaction reported herein reflects an aggregate purchase of shares at per share prices ranging from $1.35 to $1.48 inclusive. The Reporting Person further undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the manner of shares purchased at each separate price.